Once daily fast dissolving tablets of granisetron hydrochloride - Formulation and in vitro evaluation

K. Aithal, N. M. Harish, M. Rathnanand, A. Shirwaikar, M. Dutta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Recent advances in technology have presented viable dosage alternative for patients who may have difficulty in swallowing tablets or capsules. A fast dissolving tablets is one such approach. Granisetron hydrochloride is a novel anti-emetic, serotonin receptor (5-HT3) antagonist used in the prevention of chemotherapy induced nausea and vomiting. In the present study, an attempt has been made to formulate, optimize and evaluate fast dissolving tablets of granisetron hydrochloride by the use of superdisintegrants. Direct compression method was employed for cost effectiveness. A novel diluent (a combination of mannitol and silicified microcrystalline cellulose (SMCC) in the ratio 70:30 was used in the study. Formulations containing crospovidone and croscarmellose sodium displayed shortest disintegration time compared to other disintegrants. Sensory test of the prepared tablets were devoid of any grittiness.

Original languageEnglish
Pages (from-to)576-581
Number of pages6
JournalIndian Drugs
Volume43
Issue number7
Publication statusPublished - 01-07-2006

Fingerprint

Granisetron
Tablets
Serotonin 5-HT3 Receptor Antagonists
Povidone
Carboxymethylcellulose Sodium
Antiemetics
Mannitol
Deglutition
Nausea
Cost-Benefit Analysis
Capsules
Vomiting
Technology
Drug Therapy
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Aithal, K. ; Harish, N. M. ; Rathnanand, M. ; Shirwaikar, A. ; Dutta, M. / Once daily fast dissolving tablets of granisetron hydrochloride - Formulation and in vitro evaluation. In: Indian Drugs. 2006 ; Vol. 43, No. 7. pp. 576-581.
@article{f5633238913542fe8983d16f3f448147,
title = "Once daily fast dissolving tablets of granisetron hydrochloride - Formulation and in vitro evaluation",
abstract = "Recent advances in technology have presented viable dosage alternative for patients who may have difficulty in swallowing tablets or capsules. A fast dissolving tablets is one such approach. Granisetron hydrochloride is a novel anti-emetic, serotonin receptor (5-HT3) antagonist used in the prevention of chemotherapy induced nausea and vomiting. In the present study, an attempt has been made to formulate, optimize and evaluate fast dissolving tablets of granisetron hydrochloride by the use of superdisintegrants. Direct compression method was employed for cost effectiveness. A novel diluent (a combination of mannitol and silicified microcrystalline cellulose (SMCC) in the ratio 70:30 was used in the study. Formulations containing crospovidone and croscarmellose sodium displayed shortest disintegration time compared to other disintegrants. Sensory test of the prepared tablets were devoid of any grittiness.",
author = "K. Aithal and Harish, {N. M.} and M. Rathnanand and A. Shirwaikar and M. Dutta",
year = "2006",
month = "7",
day = "1",
language = "English",
volume = "43",
pages = "576--581",
journal = "Indian Drugs",
issn = "0019-462X",
publisher = "Indian Drug Manufacturers' Association",
number = "7",

}

Aithal, K, Harish, NM, Rathnanand, M, Shirwaikar, A & Dutta, M 2006, 'Once daily fast dissolving tablets of granisetron hydrochloride - Formulation and in vitro evaluation', Indian Drugs, vol. 43, no. 7, pp. 576-581.

Once daily fast dissolving tablets of granisetron hydrochloride - Formulation and in vitro evaluation. / Aithal, K.; Harish, N. M.; Rathnanand, M.; Shirwaikar, A.; Dutta, M.

In: Indian Drugs, Vol. 43, No. 7, 01.07.2006, p. 576-581.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Once daily fast dissolving tablets of granisetron hydrochloride - Formulation and in vitro evaluation

AU - Aithal, K.

AU - Harish, N. M.

AU - Rathnanand, M.

AU - Shirwaikar, A.

AU - Dutta, M.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Recent advances in technology have presented viable dosage alternative for patients who may have difficulty in swallowing tablets or capsules. A fast dissolving tablets is one such approach. Granisetron hydrochloride is a novel anti-emetic, serotonin receptor (5-HT3) antagonist used in the prevention of chemotherapy induced nausea and vomiting. In the present study, an attempt has been made to formulate, optimize and evaluate fast dissolving tablets of granisetron hydrochloride by the use of superdisintegrants. Direct compression method was employed for cost effectiveness. A novel diluent (a combination of mannitol and silicified microcrystalline cellulose (SMCC) in the ratio 70:30 was used in the study. Formulations containing crospovidone and croscarmellose sodium displayed shortest disintegration time compared to other disintegrants. Sensory test of the prepared tablets were devoid of any grittiness.

AB - Recent advances in technology have presented viable dosage alternative for patients who may have difficulty in swallowing tablets or capsules. A fast dissolving tablets is one such approach. Granisetron hydrochloride is a novel anti-emetic, serotonin receptor (5-HT3) antagonist used in the prevention of chemotherapy induced nausea and vomiting. In the present study, an attempt has been made to formulate, optimize and evaluate fast dissolving tablets of granisetron hydrochloride by the use of superdisintegrants. Direct compression method was employed for cost effectiveness. A novel diluent (a combination of mannitol and silicified microcrystalline cellulose (SMCC) in the ratio 70:30 was used in the study. Formulations containing crospovidone and croscarmellose sodium displayed shortest disintegration time compared to other disintegrants. Sensory test of the prepared tablets were devoid of any grittiness.

UR - http://www.scopus.com/inward/record.url?scp=79955406939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955406939&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 576

EP - 581

JO - Indian Drugs

JF - Indian Drugs

SN - 0019-462X

IS - 7

ER -